Stable tubule-only polypeptide (STOP) proteins are a family of microtubule associated proteins (MAPs) important in microtubule stabilization. Data indicating a role for microtubules in synaptic function has come from studies of the STOP null mouse, which exhibits synaptic deficits, in association with behavioural changes that are alleviated by antipsychotic treatment. These findings suggested that STOP mutant mice may be useful in studies of synaptic function, and could be especially relevant to schizophrenia, postulated to be a disorder of the synapse. Moreover, a genetic association between STOP and schizophrenia has been reported. This study aimed to further characterize synaptic alterations in STOP null and heterozygous mice. Using in situ hybridization histochemistry, the mRNA expression of three pre-synaptic (synaptophysin; growth associated protein-43 (GAP-43); vesicular glutamate transporter-1 (VGlut1)) and two post-synaptic (spinophilin; MAP2) proteins, was quantified in female STOP null (n = 7), heterozygous (n = 5) and wild type (n = 6) mice. For STOP null and heterozygous mice, synaptophysin, VGlut1, GAP-43 and spinophilin mRNAs were decreased in the hippocampus, whilst in addition in the null mice, synaptophysin, VGlut1 and spinophilin mRNAs were decreased in the cerebellum. Alterations in synaptic protein mRNA expression were also detected in the frontal and occipital cortex. MAP2 mRNA expression was unchanged in all brain regions. The profile of mRNA changes is broadly similar to that observed in schizophrenia. Together the data provide supporting evidence for a role for microtubules in synaptic function, and suggest that STOP, or other microtubule proteins, may contribute to the synaptic pathology of schizophrenia.
Aguezzoul M., Andrieux A., Denarier E. (2003) Overlap of promoter and coding sequences in the mouse STOP gene (Mtap6). Genomics81: 623—627
2.
Andrieux A., Salin P., Schweitzer A., Bégou M., Pachoud B., Brun P., Gory-Fauré S., Kujala P., Suaud-Chagny M., Höfle G., Job D. ( 2006) Microtubule stabilizer ameliorates synaptic function and behaviour in a mouse model for schizophrenia. Biol Psychiatry. In press
3.
Andrieux A., Salin P.A., Vernet M., Kujala P., Baratier J., Gory Faure S, Bosc C., Pointu H., Proietto D., Schweitzer A., Denarier E., Klumperman J., Job D. ( 2002) The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders. Genes Dev16: 2350—2364
4.
Arnold S.E., Lee V.M., Gur R.E., Trojanowski J.Q. (1991) Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA88: 10850—10854
5.
Baas P.W., Heidemann S.R. (1986) Microtubule reassembly from nucleating fragments during the regrowth of amputated neurites. J Cell Biol103: 917—927
6.
Bellochio E.E., Reimer R.J., Fremeau R.T. Jr, Edwards R.H. (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science289: 957—960
7.
Bellochio E.E., Hu H., Pohorille A., Chan J., Pickel V.M., Edwards R.H. (1998) The localization of the brain-specific inorganic phosphate transporter suggests a presynaptic role in glutamatergic neurotransmission . J Neurosci18: 638—659
8.
Benowitz L.I., Routtenberg A (1997) GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci20: 84—91
9.
Bianchi M., Hagan J.J., Heidbreder C.A. (2005) Neuronal plasticity, stress and depression: involvement of the cytoskeletal microtubular system? Curr Drug Targets-CNS Neurol Disord4: 597—611
10.
Bosc C., Andrieux A., Job D. ( 2003) STOP proteins. Biochemistry42: 12125—12132
11.
Bosc C., Oenarier E., Andrieux A., Job D. ( 1999) STOP proteins. Cell Struct Funct24: 393—399
12.
Brandon N.J., Handford E.J., Schurov I., Rain J.C., Pelling M., Duran Jimeniz B, Camargo L.M., Oliver K.R., Beher D., Shearman M.S., Whiting P.J. (2004) Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci25: 42—55
13.
Brun P., Begou M., Andrieux A., Mouly Badina L., Clerget M., Schweitzer A., Scarna H., Renaud B., Job D., Suaud Chagny M.F. (2005) Dopaminergic transmission in STOP null mice. J Neurochem94: 63—73
14.
Cantallops I., Routtenberg A. (1999) Activity-dependent regulation of axonal growth: posttranscriptional control of the GAP-43 gene by the NMDA receptor in developing hippocampus. J Neurobiol41: 208—220
15.
Denarier E., Fourest Lieuvin A, Bosc C., Pirollet F., Chapel A., Margolis R.L., Job D. ( 1998a) Nonneuronal isoforms of STOP protein are responsible for microtubule cold stability in mammalian fibroblasts. Proc Natl Acad Sci USA95: 6055—6060
16.
Denarier E., Aguezzoul M., Jolly C., Vourc'h C., Roure A., Andrieux A., Bosc C., Job D. ( 1998b) Genomic structure and chromosomal mapping of the mouse STOP gene (Mtap6). Biochem Biophys Res Commun243: 791—796
17.
Dent E.W., Barnes A.M., Tang F., Kalil K. (2004) Netrin-1 and semaphorin 3A promote or inhibit cortical axon branching, respectively, by reorganization of the cytoskeleton. J Neurosci24: 3002—3012
18.
Eastwood, S.L. (2003) The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? In Smythies J (ed.), Disorders of Synaptic Plasticity and Schizophrenia. International Reviews of Neurobiology, volume 59. Elsevier, Amsterdam, pp. 47—72
19.
Eastwood S.L., Harrison P.J. (1998) Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience86: 437—448
20.
Eastwood S.L., Harrison P.J. (1999) Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience93: 99—106
21.
Eastwood S.L., Harrison P.J. (2005) Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res73: 159—172
22.
Eastwood S.L., Burnet P.W., Harrison P.J. (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience66: 309—319
23.
Eastwood S.L., Burnet P W J, Harrison P.J. (2000a) Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse36:167—177.
24.
Eastwood S.L., Cairns N.J., Harrison P.J. (2000b) Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry176: 236—242
25.
Eastwood S.L., Cotter D., Harrison P.J. (2001) Cerebellar synaptic protein expression in schizophrenia . Neuroscience105: 219—229
26.
Eastwood S.L., Heffernan J., Harrison P.J. (1997) Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes. Mol Psychiatry2: 322—329
27.
Eastwood S.L., Burnet P.W., McDonald B., Clinton J., Harrison P.J. (1994) Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience59: 881—892
Feng J., Yan Z., Ferreira A., Tomizawa K., Liauw J.A., Zhuo M., Allen P.B., Ouimet C.C., Greengard P. (2000) Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA97: 9287—9292
30.
Fradley R.L., O'Meara G.F., Newman R.J., Andrieux A., Job D., Reynolds D.S. (2005) STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res163: 257—264
31.
Frankle W.G., Lerma J., Laruelle M. (2003) The synaptic hypothesis of schizophrenia. Neuron39: 205—216
32.
Fremeau R.T. Jr, Troyer M.D., Pahner I., Nygaard G.O., Tran C.H., Reimer R.J., Bellochio E.E., Fortin D., Storm-Mathisen J., Edwards R.H. (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron31: 247—260
33.
Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., Nishikawa T., Hicks G.G., Takumi T. (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol15: 587—593
34.
Galiano M.R., Bosc C., Schweitzer A., Andrieux A., Job D., Hallak M.E. (2004) Astrocytes and oligodendrocytes express different STOP protein isoforms. J Neurosci Res78: 329—337
35.
Glantz L.A., Austin M.C., Lewis D.A. (2000) Normal cellular levels of synaptophysin mRNA expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry48: 389—397
36.
Grant S G N, Marshall M.C., Page K-L., Cumiskey M.A., Armstrong J.D. (2005) Synapse proteomics of multiprotein complexes: en route from genes to nervous system diseases. Hum Mol Genet14: R225—234
37.
Guillaud L., Bosc C., Fourest Lieuvin A, Denarier E., Pirollet F., Lafanechere L., Job D. ( 1998) STOP proteins are responsible for the high degree of microtubule stabilization observed in neuronal cells. J Cell Biol142: 167—179
38.
Harrison P.J. (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology174: 151—162
39.
Harrison P.J., Eastwood S.L. (1998) Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia. Lancet352: 1669—1673
40.
Harrison P.J., Eastwood S.L. (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus11: 508—519
41.
Harrison P.J., Weinberger D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry10: 420
42.
Hirokawa N., Takemura R. (2004) Kinesin superfamily proteins and their various functions and dynamics. Exp Cell Res301: 50—59
43.
Honer W.G., Young C.E. (2003) Presynaptic proteins and schizophrenia. Int Rev Neurobiol59: 175—199
44.
Honer W.G., Young C., Falkai P. (2000) Synaptic pathology. In Harrison P J, Roberts G W (eds), The Neuropathology of Schizophrenia. Progress and Interpretation. Oxford University Press, Oxford, pp. 105—136
45.
Jan Y.N., Jan L.Y. (2003) The control of dendrite development. Neuron40: 229—242
46.
Kalil K., Dent E.W. (2005) Touch and go: guidance cues signal to the growth cone cytoskeleton. Curr Opin Neurobiol15: 521—526
47.
Kamiya A., Kubo K., Tomoda T., Takaki M., Youn R., Ozeki Y., Sawamura N., Park U., Kudo C., Okawa M., Ross C.A., Hatten M.E., Nakajima K., Sawa A. ( 2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol7: 1067—1078
48.
Karson C.N., Mrak R.E., Schluterman K.O., Sturner W.Q., Sheng J.G., Griffin W.S. (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for `hypofrontality'. Mol Psychiatry4: 39—45
49.
Katsetos C.D., Hyde T.M., Herman M.M. (1997) Neuropathology of the cerebellum in schizophrenia — an update: 1996 and future directions. Biol Psychiatry42: 213—224
50.
Kerwin R.W. (1993) Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis. Psychol Med23: 547—551
51.
Law A.J., Hutchinson L.J., Burnet P.W., Harrison P.J. (2004a) Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex. J Neurosci Res76: 376—382
52.
Law A.J., Weickert C.S., Hyde T.M., Kleinman J.E., Harrison P.J. (2004b) Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiatry161: 1848—1855
53.
Lipska B.K., Peters T., Hyde T.M., Halim N., Horowitz C., Mitkus S., Weickert C.S., Matsumoto M., Sawa A., Straub R.E., Vakkalanka R., Herman M.M., Weinberger D.R., Kleinman J.E. (2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet15: 1245—1258
54.
Liu Z., Steward R., Luo L. ( 2000) Drosophila Lis1 is required for neuroblast proliferation, dendritic elaboration and axonal transport. Nat Cell Biol2: 776—783
55.
Mack T.G., Koester M.P., Pollerberg G.E. (2000) The microtubule-associated protein MAP1B is involved in local stabilization of turning growth cones. Mol Cell Neurosci15: 51—65
56.
Marquèze Pouey B, Wisden W., Malosio M.L., Betz H. ( 1991) Differential expression of synaptophysin and synaptoporin mRNAs in the postnatal rat central nervous system. J Neurosci11: 3388—3397
57.
Masliah E., Terry R.D., Alford M., DeTeresa R. (1990) Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem38: 837—844
58.
Mirnics K., Middleton F.A., Lewis D.A., Levitt P. (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci24: 479—486
59.
Miyazaki T., Fukaya M., Shimizu H., Watanabe M. (2003) Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum. Eur J Neurosci17: 2563—2572
60.
Moises H.W., Zoega T., Gottesman I.I. (2002) The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry2: 8
61.
Moores C.A., Perderiset M., Francis F., Chelly J., Houdusse A., Milligan R.A. (2004) Mechanism of microtubule stabilization by doublecortin . Mol Cell14: 833—839
62.
Okada Y., Yamazaki H., Sekine Aizawa Y, Hirokawa N. (1995) The neuronspecific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell81: 769—780
63.
Paxinos G., Franklin K B J (2004) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA
64.
Pollard H., Khrestchatisky M., Moreau J., Ben Ari Y., Represa A. (1994) Correlation between reactive sprouting and microtubule protein expression in epileptic hippocampus. Neuroscience61: 773—787
Schaefer A.W., Kabir N., Forscher P. (2002) Filopodia and actin arcs guide the assembly and transport of two populations of microtubules with unique dynamic parameters in neuronal growth cones. J Cell Biol158: 139—152
67.
Scott E.K., Luo L. ( 2001) How do dendrites take their shape?Nat Neurosci4: 359—365
68.
Sergé A., Fourgeaud L., Hemar A., Choquet D. (2003) Active surface transport of metabotropic glutamate receptors through binding to microtubules and actin flow. J Cell Sci116: 5015—5022
69.
Shimizu H., Iwayama Y., Yamada K., Toyota T., Minabe Y., Nakamura K., Nakajima M., Hattori E., Mori N., Osumi N., Yoshikawa T. (2006) Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. Schizophr Res84: 244—252
70.
Suter D.M., Forscher P. (2000) Substrate-cytoskeletal coupling as a mechanism for the regulation of growth cone motility and guidance. J Neurobiol44: 97—113
71.
Takei Y., Teng J., Harada A., Hirokawa N. (2000) Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J Cell Biol150: 989—1000
72.
Tanaka E., Kirschner M.W. (1995) The role of microtubules in growth cone turning at substrate boundaries. J Cell Biol128: 127—137
Tucker R.P., Garner C.C., Matus A. (1989) In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron2: 1245—1256
75.
van Rossum D., Hanisch U.K. (1999) Cytoskeletal dynamics in dendritic spines: direct modulation by glutamate receptors? Trends Neurosci22: 290—295
76.
Washbourne P., Bennett J.E., McAllister A.K. (2002) Rapid recruitment of NMDA receptor transport packets to nascent synapses. Nat Neurosci5: 751—759
77.
Washbourne P., Liu X.B., Jones E.G., McAllister A.K. (2004) Cycling of NMDA receptors during trafficking in neurons before synapse formation. J Neurosci24: 8253—8264
78.
Webster M.J., Shannon Weickert C, Herman M.M., Hyde T.M., Kleinman J.E. (2001) Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia. Schizophr Res49: 89—98
79.
Weickert C.S., Webster M.J., Hyde T.M., Herman M.M., Bachus S.E., Bali G., Weinberger D.R., Kleinman J.E. (2001) ReducedGAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. Cereb Cortex11: 136—147
80.
Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., Herman M.M., Weinberger D.R., Kleinman J.E. (2004) Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry61: 544—555
81.
Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., Berman K.F., Goldberg T.E. (2001) Prefrontal neurons and the genetics of schizophrenia . Biol Psychiatry50: 825—844
82.
Williamson T., Gordon Weeks P.R., Schachner M., Taylor J. (1996) Microtubule reorganization is obligatory for growth cone turning. Proc Natl Acad Sci USA93: 15221—15226
83.
Yonekawa Y., Harada A., Okada Y., Funakoshi T., Kanai Y., Takei Y., Terada S., Noda T., Hirokawa N. (1998) Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol141: 431—441
84.
Yu W., Cook C., Sauter C., Kuriyama R., Kaplan P.L., Baas P.W. (2000) Depletion of a microtubule-associated motor protein induces the loss of dendritic identity. J Neurosci20: 5782—5791
85.
Yuen E.Y., Jiang Q., Feng J., Yan Z. ( 2005) Microtubule regulation of N-methyl-D-aspartate receptor channels in neurons. J Biol Chem280: 29420—29427
86.
Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., Hirokawa N. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell105: 587—597
